Showing results (531-540 of 550) with videos related to
Sort By:
Pageof 55
Blood Advances|January 31, 2022
Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method surveyR Andrew Harkins, Sharvil P Patel, Michelle J Lee, et al.Blood Advances|December 3, 2025
Consensus Recommendations from the 2024 International Follicular Lymphoma Scientific WorkshopReid W Merryman, Sarah C Rutherford, Stephen M Ansell, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2016
US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816Oliver W Press, Hongli Li, Heiko Schöder, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2014
Active idiotypic vaccination versus control immunotherapy for follicular lymphomaRonald Levy, Kristen N Ganjoo, John P Leonard, et al.Blood|May 31, 2024
Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCLMitchell R Smith, Opeyemi A Jegede, Peter Martin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2019
Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell LymphomaOwen A O'Connor, Muhit Özcan, Eric D Jacobsen, et al.Blood Advances|February 18, 2026
Patterns of Care and Clinical Outcomes in Systemic Peripheral T-cell Lymphoma: The LEO-MER Prospective Cohort StudyJia Ruan, Zhengming Chen, Melissa C Larson, et al.British Journal of Haematology|October 31, 2017
Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-RLisa Giulino-Roth, Tara O'Donohue, Zhengming Chen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2019
Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303Nancy L Bartlett, Wyndham H Wilson, Sin-Ho Jung, et al.Neuro-Oncology Advances|January 28, 2022
Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trialCorinne E Griguer, Claudia R Oliva, Christopher S Coffey, et al.Pageof 55